Two Ex-Heritage Pharma Execs Admit To Manipulating Generic Prices

Heritage generics deal

Two former Heritage Pharmaceuticals executives–Jeffrey A. Glazer and Jason T. Malek–have admitted to manipulating the price of a company antibiotic and diabetes drug between 2013 and 2015. Glazer was the company’s chief executive and chairman at the time, while Malek was the company’s senior vice president of commercial operations. Both men face up to 10 years in prison.

Read the source article at

About the Author

Related Posts

Leave a Reply